- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01112280
Efficacy of Cap-assisted Chromoendoscopy as a Screening Test for Colorectal Neoplasm Using Web-based Research Network (CapACE)
December 11, 2018 updated by: Hyun-Soo Kim, Korean Association for the Study of Intestinal Diseases
Prospective Randomized Controlled Trial of Cap-Assisted ChromoEndoscopy(CapACE) Versus Conventional Colonoscopy(CC) for the Detection of Colorectal Neoplasia
The investigators plan to conduct a multi-center, randomized controlled trial to investigate the efficacy of cap-assisted chromoendoscopy as a screening test for detection of colorectal polyp.
This study will be performed using web-based research network, e-VELOS in Korea.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Various endoscopic tools have been tried to reduce polyp missing rate which has been reported to be 20-25%.
Transparent cap-assisted colonoscopy has been suggested to improve visualization of the lesion that are difficult to access, such as tangentially located lesions and those located within a limited luminal space.
Chromoendoscopy with indigocarmine spraying was reported to increases the detection rates of polyp, especially in right colon and rectum.
However, there also have been mixed results regarding polyp detection rates of the endoscopic methods.
Moreover, there is no data regarding the impact of the screening tools on longterm recurrence rate of colorectal polyp.
Therefore, in this study, we intend to perform a multi-center, randomized controlled trial to investigate the efficacy of cap-assisted chromoendoscopy as a screening test for detection of colorectal polyps.
This study will be performed using web-based research network, e-VELOS in Korea.
Study Type
Interventional
Enrollment (Actual)
1905
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Anyang, Korea, Republic of
- Hallym University Medical Center
-
Busan, Korea, Republic of
- Kosin University College of Medicine
-
Cheonan, Korea, Republic of
- Dankuk University college of medicine hospital
-
Goyang, Korea, Republic of
- National Cancer Center Hospital, National Cancer Center
-
Guri-si, Korea, Republic of
- Hanyang University Guri Hospital, Hanyang University College of Medicine
-
Incheon, Korea, Republic of
- Catholic university St. Mari's hospital
-
Seoul, Korea, Republic of
- Samsung Medical Center, Sungkyunkwan University School of Medicine
-
Seoul, Korea, Republic of
- Yonsei University College of Medicine
-
Seoul, Korea, Republic of
- Asan Medical Center, University of Ulsan College of Medicine
-
Seoul, Korea, Republic of
- Ewha Mokdong hospital
-
Seoul, Korea, Republic of
- Kyung Hee University Hospital at Gang Dong, Kyung Hee University School of Medicine
-
Seoul, Korea, Republic of
- Sunchunhyang University hospital
-
Seoul, Korea, Republic of
- Sungkyunkwan University Kangbuk Samsung Hospital
-
Wonju, Korea, Republic of
- Yonsei Uiniversity Wonju College of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
45 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- All asymptomatic colonoscopic examinees
Exclusion Criteria:
- Familial history of hereditary colorectal cancer
- History of colorectal cancer
- Patients had received colonoscopy examination before
- Familial or past history of FAP(familiar adenomatous polyposis)
- Colonic polyposis syndrome
- Prior colonic resection of any part of the colon
- Allergy to indigo carmine
- Inflammatory bowel disease
- Pregnancy
- Inability to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: cap-assisted chromoendoscopy
To the tip of the colonoscope, transparent cap is fitted and applied.
In addition, panchromoendoscopy using indigocarmine solution is preformed in this group.
|
A cap (irrigation cap) is a simple plastic device that can be attached to the tip of a colonoscope before performing the colonoscopy.
For chromoendoscopy, 0.09% indigocarmine was administered via irrigation cap .
|
No Intervention: Standard colonoscopy
Neither transparent cap nor chromoendoscopy is applied in this group and standard colonoscopy is performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
|
The proportion of subjects with at least one adenoma
|
7 days is needed to confirm the pathologic examination.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proximal adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
|
Proportion of subjects with at least one proximal colon adenoma
|
7 days is needed to confirm the pathologic examination.
|
Proximal serrated polyp detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
|
Proportion of subjects with at least one proximal serrated polyp/adenoma
|
7 days is needed to confirm the pathologic examination.
|
Advanced adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
|
Proportion of subjects with at least one advanced adenoma
|
7 days is needed to confirm the pathologic examination.
|
Serrated adenoma detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
|
Proportion of subjects with at least one serrated adenoma
|
7 days is needed to confirm the pathologic examination.
|
Cancer detection rate
Time Frame: 7 days is needed to confirm the pathologic examination.
|
Proportion of subjects with at least one cancer
|
7 days is needed to confirm the pathologic examination.
|
Surveillance
Time Frame: 7 - 14 days
|
Surveillance interval recommendations for both groups were classified based on adenoma detection
|
7 - 14 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Hyun Soo Kim, Korean Association for the Study of Intestinal Diseases
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2010
Primary Completion (Actual)
March 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
April 26, 2010
First Submitted That Met QC Criteria
April 27, 2010
First Posted (Estimate)
April 28, 2010
Study Record Updates
Last Update Posted (Actual)
December 13, 2018
Last Update Submitted That Met QC Criteria
December 11, 2018
Last Verified
December 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KASID polyp-01
- MHWFA A092230 (Other Grant/Funding Number: Ministry of Health, Welfare & Family Affairs, Korea)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Neoplasm
-
Azienda Ospedaliera di PadovaIstituto Oncologico Veneto IRCCSRecruitingColorectal Adenocarcinoma | Colorectal Liver Metastases | Unresectable Malignant NeoplasmItaly
-
Carol Davila University of Medicine and PharmacyRecruitingNeoplasm, Colorectal | Neoplasm, Stomach | Neoplasm, Esophagus | Neoplasm, DuodenalRomania
-
Koen RoversHoffmann-La Roche; Comprehensive Cancer Centre The Netherlands; Dutch Cancer...RecruitingColorectal Cancer | Peritoneal Neoplasms | Colorectal Neoplasm | Peritoneal Carcinomatosis | Colorectal Carcinoma | Peritoneal Cancer | Peritoneal Metastases | Colorectal Adenocarcinoma | Colorectal Neoplasms Malignant | Peritoneal Neoplasm Malignant Secondary Carcinomatosis | Peritoneal Neoplasm Malignant...Netherlands, Belgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingMetastatic Malignant Neoplasm in the Liver | Advanced Malignant Neoplasm | Refractory Malignant Neoplasm | Colorectal Carcinoma Metastatic in the LiverUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Recurrent Colorectal Carcinoma | Metastatic Malignant Neoplasm in the Liver | Metastatic Colorectal Carcinoma | Metastatic Malignant Neoplasm in the Lung | Resectable Colorectal CarcinomaUnited States
-
Mayo ClinicRecruitingColorectal Cancer | Colorectal Liver MetastasesUnited States
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityUnknownColorectal Cancer | Neoplasm | Metastatic NeoplasmChina
-
TransgeneTerminatedColorectal Neoplasm | Digestive System NeoplasmFrance, Spain, Belgium
-
Fundació Institut de Recerca de l'Hospital de la...UnknownColorectal Cancer | AngiogenesisSpain
-
Bristol-Myers SquibbNovartisActive, not recruitingColorectal Cancer | Colorectal Neoplasm | Colorectal Tumors | Colorectal CarcinomaItaly, United States, Canada, Spain, Argentina, Australia, Belgium, Chile, Czechia, Germany
Clinical Trials on cap-assisted chromoendoscopy
-
Chinese University of Hong KongCompletedColonoscopy | Lower Gastrointestinal TractChina
-
The Second Hospital of Nanjing Medical UniversityRecruitingRectal Prolapse | Internal HemorrhoidChina
-
Indiana UniversityCompletedPolypsUnited States
-
Technical University of MunichCompletedDuodenal Papilla, MajorGermany
-
The Catholic University of KoreaUnknown
-
Technical University of MunichRotkreuzklinikum München gGmbH; Klinikum Freising; Klinikum Landshut-Achdorf; Städtisches... and other collaboratorsCompletedEndoscopic Diagnosis in EsophagusGermany
-
Dalin Tzu Chi General HospitalCompletedColonoscopy | Intubation Time | Cap-assisted ColonoscopyTaiwan
-
Faming ZhangRecruiting
-
American Society for Gastrointestinal EndoscopyMidwest Biomedical Research FoundationUnknownAdenoma | Colon Cancer | Colon PolypsUnited States
-
London North West Healthcare NHS TrustCompletedColonic Neoplasms | Colo-rectal Cancer | Colon Adenoma | Adenomas SerratedUnited Kingdom